A Study of Multiparametric MRI and pHLIP® ICG in Breast Cancer Imaging During Surgery
Recruiting
Phase 1
Phase 2
Interventional Study
Breast Cancer
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Prior Safety Data
This treatment has already been tested in at least one earlier human trial.
At a Glance
- Age
- 18 and older
- Sex
- Female
- Trial phase
- Phase 1/2
- Study type
- Interventional
- Purpose
- Diagnostic
- Participants needed
- 55 (estimated)
- Sponsor
- Memorial Sloan Kettering Cancer Center · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The purpose of this study is to find out whether pre-operative mpMRI using additional MRI sequences may improve surgical outcomes by providing more accurate information about the extent and acidity of the tumor than standard MRI, and to see whether the use of the fluorescent imaging agent pHLIP ICG and NIRF imaging during surgery is a safe approach that may allow the surgeon to see the tumor and n…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Age 18 years or greater
* Biopsy proven primary breast malignancy (BI-RADS 6)
* Tumor stage Tis, T1 and T2, lesion size \> 1 cm
* Primary surgical treatment with breast conservation
* No previous treatment
* ECOG performance of 0-2
Exclusion Criteria:
* Life expectancy \< 3 …
Contacts
Monica Morrow, MD
646-888-5350
CONTACT